Table 2.
Evaluation of apoptosis percentage in CD4+ /CCR5+ and CD4+ CCR3+ T lymphocytes inside the total CD4+ CCR5+ and CD4+ CCR3+ T populations using PI method after TCR activation by Lag
% apoptosis | ||||
---|---|---|---|---|
CD4+ /CCR5+ | CD4+ /CCR3 | |||
− | + | − | + | |
Acute (A) | 10·0 ± 2 | 35·0 ± 8* | 2·5 ± 0·8 | 1·5 ± 0·5 |
Healed (B) | 7·5 ± 1 | 5·0 ± 1 | 2·0 ± 1·0 | 2·5 ± 1·0 |
Frozen PBMC from five VL patients, studied in acute and healed phases of disease, were cultured for 24 hr in medium alone (–) or in the presence of LAg (+) (2 × 10 7 equivalent promastigotes). Cells were treated with IS3-conjugated antibody anti-CD4, with anti-CCR5 or anti-CCR3 FICT-conjugated antibodies and incubated with PI. Data are expressed as mean percentage ±SE.
P < 0·05: significant different from healed subjects.